MR1 ESGE recommends the following standards for Barrett esophagus (BE) surveillance:–a
minimum of 1-minute inspection time per cm of BE length during a surveillance endoscopy …

The incidence of esophageal carcinoma continues to increase whilst its prognosis remains
poor. The most dramatic reduction in mortality is likely to follow early diagnosis of the …

Background Esophageal cancer (EC) is a prevalent malignancy characterized by a low 5-
year survival rate, primarily attributed to delayed diagnosis and limited therapeutic options …

METHODS: BE cases had≥ 1 cm of circumferential BE with intestinal metaplasia; controls
had no endoscopic evidence of BE. The SOS device was withdrawn 8 minutes after …

Background and Aims We previously identified a 5 methylated DNA marker (MDM) panel for
the detection of nonendoscopic Barrett's esophagus (BE). In this study, we aimed to …

Accurate and rapid point-of-care tissue and microbiome sampling is critical for early
detection of cancers and infectious diseases and often result in effective early intervention …

Barrett esophagus (BE) is the only known premalignant precursor to esophageal
adenocarcinoma (EAC), a deadly malignancy that carries a dismal prognosis. Guidelines …

Barrett esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC),
a cancer that continues to have a poor 5-year survival rate of 20%. Current BE screening …

Barrett's esophagus (BE) is a metaplastic columnar epithelial change that results from
chronic esophageal mucosal injury to the normal squamous esophageal mucosa. 1 BE …

Abstract Purpose of Review Esophageal adenocarcinoma (EAC) is a lethal disease with
rapidly rising incidence. Screening for EAC and its metaplastic precursor, Barrett's …